In the BioHarmony Drug Report Database
Doravirine
Pifeltro (doravirine) is a small molecule pharmaceutical. Doravirine was first approved as Pifeltro on 2018-08-30. It is used to treat hiv-1 in the USA. It has been approved in Europe to treat HIV infections. Delstrigo’s patent is valid until 2031-10-07 (FDA).
Trade Name
|
Pifeltro |
|---|---|
Common Name
|
doravirine |
ChEMBL ID
|
CHEMBL2364608 |
Indication
|
hiv infections, hiv-1 |
Drug Class
|
Antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives |
Image (chem structure or protein)